NSETrading Window26 Jun 2026 · 26 Jun 2026, 09:53 am
Trading Window
Ajanta Pharma Limited · AJANTPHARM
✦ AI Summary
Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
AJANTPHARM_26062026095322_TWClosure30062026.pdf
View document text
Ajanta Pharma Limited
Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000
Road, Chakala, Andheri (E), E legal.info@ajantapharma.com
Mumbai 400 093, India W www.ajantapharma.com
26th June 2026
BSE Limited National Stock Exchange of India
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/l,
Dalal Street, G block, Bandra Kurla Complex,
Mumbai - 400 001 Bandra (East), Mumbai - 400 051
Scrip Code: BSE - AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ
Re: Closure of Trading Window
Dear Sir/Madam,
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended
from time to time and “Ajanta’s Code of Conduct for Insiders”, the Trading Window for
dealing in securities of the Company shall remain closed from Wednesday, 1st July 2026 till 48
hours after the declaration of Financial Results of the Company for the quarter ended 30th June
2026.
Kindly take the above information on record.
Thanking you,
Yours faithfully,
Gaurang Shah
Sr. VP- Legal & Company Secretary
Corporate Identity Number - L24230MH1979PLC022059